Fuji Aspire HD Gets FDA Nod

Julie Ritzer Ross | | Radiology Business | Business Intelligence
Fujifilm Medical Systems USA yesterday announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Aspire HD flat-panel, full-field digital mammography (FFDM) system. The clearance enables the company to offer mammography systems using flat-panel digital radiography and computed radiography approaches alike. Aspire HD has a proprietary detector that utilizes dual-layer amorphous selenium (a-Se) and Fuji's direct optical switching (DOS) technology. The latter combines with Fuji’s 50-µm resolution to afford enhanced visualization, according to the compay. Meanwhile, the DOS technology eliminates the need for the thin-film transistors (TFTs) commonly found in currently available flat-panel FFDM systems. The new technology enables a “direct image transfer” process that produces less noise, according to the company. To read the press release, click here: http://www.prnewswire.com/news-releases/fujifilms-aspire-hd-receives-fda-clearance-129642078.html

Julie Ritzer Ross,

Contributor

Related Content

Orano Med breaks ground on $265M thorium production site
Image-interpretation market scoreboard: Radiologists 72%, others 28%
Lantheus lands rights to budding radiopharmaceuticals for initial outlay of $35M
17 short-term strategies to address the national radiologist shortage
‘SR’ onboards another independent practice, its 1st in the Natural State
Analysis: Allied radiology professionals generate millions of dollars per year in indirect revenues alone

Around the web

Health Imaging
Nearly $800,000 settlement offered to family of man who died during MRI exam

The patient, who was being cared for in the ICU, was not accompanied or monitored by nursing staff during his exam, despite being sedated.

Cardiovascular Business
Global shortage of nuclear imaging isotopes may be over

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

Cardiovascular Business
‘A huge win’: CMS significantly increases Medicare payments for cardiac CT

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.